PURACAP PHARM LLC
GenericsPURACAP PHARM LLC is a generic drug manufacturer focused on Immunology.
PURACAP PHARM LLC's Key Drugs
PURACAP PHARM LLC's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
PURACAP PHARM LLC's Recent FDA Approvals
New NDA/BLA approvals for PURACAP PHARM LLC over the last two years — novel drugs only, excluding generics and label supplements.
PURACAP PHARM LLC's Therapeutic Areas
PURACAP PHARM LLC's approved drugs and pipeline span 1 therapeutic area, led by Immunology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
PURACAP PHARM LLC's Top Competitors
PURACAP PHARM LLC's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Novartis, and AbbVie. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
PURACAP PHARM LLC Pipeline Snapshot
Active clinical trials for PURACAP PHARM LLC across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Immunology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1974-10-22
- Latest
- 2024-12-16
- Applications
- 15